Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.
Vial Size: 3ml
Form: White Lyophilized Powder
CAS Number: 137525-51-0
Chemical Name: Body Protection Compound-157 (BPC-157)
Synonyms: BPC157; Bepecin; PL 14736; Pentadecapeptide BPC 157
Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1,419.5 g/mol
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; 15-amino acid synthetic analog of a cytoprotective portion of human gastric juice Body Protection Compound
Purity: ≥99% (HPLC) — see batch COA
Form: Lyophilized white to off-white powder
Storage Conditions: Store at −20°C, desiccated, protected from light. Stable 24 months lyophilized.
Solubility: Soluble in sterile water or 0.5% acetic acid at ≥1 mg/mL
Receptor Activity: Studied for upregulation of growth factor expression (VEGF, EGF), modulation of nitric oxide synthesis pathways, and angiogenic signaling in gastric mucosal and endothelial cell models
Certificate of Analysis: Available for all batches.
For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.
Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.
Vial Size: 3ml
Form: White Lyophilized Powder
CAS Number: 137525-51-0
Chemical Name: Body Protection Compound-157 (BPC-157)
Synonyms: BPC157; Bepecin; PL 14736; Pentadecapeptide BPC 157
Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1,419.5 g/mol
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; 15-amino acid synthetic analog of a cytoprotective portion of human gastric juice Body Protection Compound
Purity: ≥99% (HPLC) — see batch COA
Form: Lyophilized white to off-white powder
Storage Conditions: Store at −20°C, desiccated, protected from light. Stable 24 months lyophilized.
Solubility: Soluble in sterile water or 0.5% acetic acid at ≥1 mg/mL
Receptor Activity: Studied for upregulation of growth factor expression (VEGF, EGF), modulation of nitric oxide synthesis pathways, and angiogenic signaling in gastric mucosal and endothelial cell models
Certificate of Analysis: Available for all batches.
For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.

